Suzuki, H.;                     Kitamura, K.;                     Goto, N.;                     Ishikawa, K.;                     Ouchida, T.;                     Tanaka, T.;                     Kaneko, M.K.;                     Kato, Y.    
        A Novel Anti-CD44 Variant 3 Monoclonal Antibody C44Mab-6 Was Established for Multiple Applications. Int. J. Mol. Sci. 2023, 24, 8411.
    https://doi.org/10.3390/ijms24098411
    AMA Style
    
                                Suzuki H,                                 Kitamura K,                                 Goto N,                                 Ishikawa K,                                 Ouchida T,                                 Tanaka T,                                 Kaneko MK,                                 Kato Y.        
                A Novel Anti-CD44 Variant 3 Monoclonal Antibody C44Mab-6 Was Established for Multiple Applications. International Journal of Molecular Sciences. 2023; 24(9):8411.
        https://doi.org/10.3390/ijms24098411
    
    Chicago/Turabian Style
    
                                Suzuki, Hiroyuki,                                 Kaishi Kitamura,                                 Nohara Goto,                                 Kenichiro Ishikawa,                                 Tsunenori Ouchida,                                 Tomohiro Tanaka,                                 Mika K. Kaneko,                                 and Yukinari Kato.        
                2023. "A Novel Anti-CD44 Variant 3 Monoclonal Antibody C44Mab-6 Was Established for Multiple Applications" International Journal of Molecular Sciences 24, no. 9: 8411.
        https://doi.org/10.3390/ijms24098411
    
    APA Style
    
                                Suzuki, H.,                                 Kitamura, K.,                                 Goto, N.,                                 Ishikawa, K.,                                 Ouchida, T.,                                 Tanaka, T.,                                 Kaneko, M. K.,                                 & Kato, Y.        
        
        (2023). A Novel Anti-CD44 Variant 3 Monoclonal Antibody C44Mab-6 Was Established for Multiple Applications. International Journal of Molecular Sciences, 24(9), 8411.
        https://doi.org/10.3390/ijms24098411